- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Novartis India has announced a postal ballot seeking shareholder approval for two key items: the re-appointment of Mr. Sanker Parameswaran as an Independent Director for a second five-year term, recognizing his extensive legal and corporate governance expertise; and entering into a related party transaction with Novartis Pharma AG for the purchase and import of pharmaceutical finished products. The latter transaction, essential for maintaining supply of key brands in India, is capped at INR 300 Crores annually for five years and has Audit Committee backing. Shareholders will vote electronically to approve these resolutions.